Plasminogen (PLG) (N-Term) Peptide
Quick Overview for Plasminogen (PLG) (N-Term) Peptide (ABIN8108304)
Target
Origin
Source
Application
-
-
Protein Region
- N-Term
-
Purpose
- PLG Peptide - N-terminal region
-
Sequence
- KSSIIIRMRD VVLFEKKVYL SECKTGNGKN YRGTMSKTKN GITCQKWSST
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
This is a synthetic peptide designed for use in combination with anti-PLG Antibody (ARP76467_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- PLG (Plasminogen (PLG))
-
Background
- The protein encoded by this gene is a secreted blood zymogen that is activated by proteolysis and converted to plasmin and angiostatin. Plasmin dissolves fibrin in blood clots and is an important protease in many other cellular processes while angiostatin inhibits angiogenesis. Defects in this gene are likely a cause of thrombophilia and ligneous conjunctivitis. Two transcript variants encoding different isoforms have been found for this gene.
-
Molecular Weight
- 89 kDa
-
Gene ID
- 5340
-
NCBI Accession
- NP_000292
-
UniProt
- P00747
Target
-